We are live on ! Find out more
BIOT

Biotech Acquisition Company Class A Ordinary Shares

Delisted

BIOT was delisted on the 2nd of February, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
1
JP Morgan Chase
New York
$20M +$19.8M +2,016,756 New
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$12.5M +$7.37M +751,824 +147%
AC
3
Aristeia Capital
Connecticut
$11.4M
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$9.2M
CCP
5
Corbin Capital Partners
New York
$9.19M
Marshall Wace
6
Marshall Wace
United Kingdom
$9.08M
SCM
7
Saba Capital Management
New York
$8.96M
CM
8
Cohanzick Management
New York
$7.91M
RA
9
RiverPark Advisors
New York
$7.91M
LA
10
Linden Advisors
New York
$6.72M
FTCM
11
Fir Tree Capital Management
New York
$6.4M -$308K -31,453 -5%
GCL
12
Glazer Capital LLC
New York
$6.3M +$6.24M +636,083 New
RL
13
RPO LLC
Connecticut
$6.22M +$4.5M +458,817 +270%
MI
14
MMCAP International
Cayman Islands
$5.93M
PAMP
15
Polar Asset Management Partners
Ontario, Canada
$5.61M
AWG
16
Alpha Wave Global
New York
$5.27M +$658K +67,150 +14%
WCMNY
17
Westchester Capital Management (New York)
New York
$5.15M
PC
18
Periscope Capital
Ontario, Canada
$4.95M -$2.54M -258,902 -34%
Millennium Management
19
Millennium Management
New York
$4.54M -$1.39M -142,155 -24%
DKCM
20
Davidson Kempner Capital Management
New York
$4.42M
RCM
21
Radcliffe Capital Management
Pennsylvania
$4.02M
Nomura Holdings
22
Nomura Holdings
Japan
$3.95M
MF
23
Magnetar Financial
Illinois
$3.76M -$380K -38,798 -9%
AA
24
AQR Arbitrage
Connecticut
$3.48M +$2.45M +250,000 +247%
BFM
25
Boothbay Fund Management
New York
$3.21M +$2.34M +238,910 +281%